Mkts

Abeona Therapeutics Inc.

NASDAQ: ABEO
$2.42+0.13 (+5.68%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
2.092.44
52-week range
2.227.65
Today
Open2.33
Previous close2.42
Volume819.5K
Valuation
Market cap126.58M
P/E ratio—
EPS (TTM)-1.12
Income & risk
Dividend / yield—
Beta1.66
Avg volume1.55M
Discussion

ABEO News

Stories mentioning ABEO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue8,720400.00
Cost of Goods Sold2,696488.00
Gross Profit6,024(488.00)0.000.000.000.00
Operating Expenses
Research & Development9,5556,7124,2165,9439,9418,9948,9419,218
Sales General & Admin19,50218,78219,31417,1499,7866,4048,646
Total Operating Expenses23,19219,72716,67215,34517,864
Operating Income (Loss)(23,033)(22,911)(24,018)(22,792)(19,727)(16,672)(15,345)(17,864)
Interest Income
Interest Expense830.00884.00901.00957.00998.001,0821,1021,072
Other Expense
Pretax Income(17,073)(20,675)(20,358)124,345(12,029)(30,269)7,406
Tax Provision2.00(15,197)15,512
Net Income (Loss)(17,075)(20,460)(5,161)108,833(12,029)(9,293)(30,269)7,406
Earnings Per Share (Basic)(0.30)(0.39)(0.10)2.07(0.24)(0.23)(0.63)0.19
Earnings Per Share (Diluted)(0.30)(0.31)(0.10)1.71(0.24)(0.23)(0.63)(0.26)
Weighted Average Shares Outstanding (Basic)56,62152,95354,24352,52549,77941,04848,08240,010
Weighted Average Shares Outstanding (Diluted)56,62166,13654,24366,64149,77941,04848,08251,227

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ABEO

Abeona Therapeutics Inc. (NASDAQ: ABEO) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABEO. It last traded at $2.42 (Nov 13, 2026, 4:00 PM ET), up 5.7% on the day. That gives Abeona Therapeutics a market capitalisation of $126.6M.

Over the past 52 weeks ABEO has traded between $2.22 and $7.65.

Revenue for the quarter ended Mar 31, 2026 was $8.7M; a net loss of $17.1M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$8.7M-$17.1M-195.8%
Dec 31, 2025—-$20.5M—
Sep 30, 2025—-$5.2M—
Jun 30, 2025$400.0K$108.8M27208.3%

From Abeona Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…